Detecting, localizing, and targeting internal sites in vivo using optical contrast agents

A medical system for determining the presence and concentration of a drug within a target tumor during or shortly after administration of an optically detectable drug, comprising:

• (a) a contrast solution of the optically active drug for providing a source of contrast between said target tumor and other tissues, said agent infused into a vein so as to have achieved distribution and localization within the target tumor;
• (b) a white light source for illuminating a portion of said subject with illuminating radiation;
• (c) a light collector for collecting a portion of said illuminating radiation, said collected portion having passed through an opaque region of the body of the subject potentially containing said contrast agent, and for providing a contrast influenced detected signal in response to said collected portion;
• (d) a needle for insertion into said subject during or shortly after administration of an optically detectable drug, said needle coupled to said light emitter, said light collector, or both;
• and,
• (e) means for determining the presence of said drug, said determination based upon said detected signal, and for generating an output signal related to a distribution and localization of said drug levels within said target tissue in response to said determination.

A medical imaging system for determining the margins of a tumor during prostatectomy after administration of an optically detectable drug, comprising:

• (a) a fluorescent contrast agent targeted to prostate-specific surface antigens for providing a source of contrast between cells of prostate origin and other normal or abnormal tissues, said agent injected intravenously so as to have achieved distribution and localization within the body;
• (b) a monochromatic intensity modulated light source for illuminating the prostate with illuminating radiation, said distributed contrast agent at least potentially disposed to fluoresce in response to said illuminating radiation;
• (c) a medical CCD camera device for collecting a portion of said fluorescent radiation, said collected portion having passed through an opaque region of the prostate, and for providing a detected phase and intensity signal in response to said collected portion, said camera optically coupled to the body, and,
• (d) means for determining the presence and location of prostate cells based upon said detected signal, and for generating an output image related to a distribution and localization of said contrast agent in response to said determination.

A method for detecting and imaging metastatic tumor within the body of a patient using a medical imaging camera device, comprising:

• (a) intravenously administering an optical contrast agent to the subject, said agent targeted toward one or more tissue-specific antigens;
• (b) waiting until the contrast agent has achieved adequate distribution and localization within the body;
• (c) providing a noninvasive medical CCD camera device that is optically coupled to a light source, a light detector, or both, and using the device or instrument during a partial or total body scan imaging procedure on the subject;
• (d) illuminating the subject with light from the light source such that the contrast agent in vivo may interact with and modify the illuminating light;
• (e) detecting modified light with the light detector after passage of source light through an opaque region of the body and possible interaction and modification of the source light by the contrast agent;
• (f) determining a positional estimate of one or more metastatic cancers types and sites based upon said modified, detected light;
• and,
• (g) generating an output image in response to said measurement.

A method for detecting and treating metastatic tumor within the body of a patient using a medical imaging camera device, comprising:

• (a) intravenously administering an optical contrast agent to the subject;
• (b) waiting until the contrast agent has achieved adequate distribution and localization within the body;
• (c) providing a noninvasive medical CCD camera device that is optically coupled to a light source, a light detector, or both, and using the device or instrument during a partial or total body scan imaging procedure on the subject;
• (d) illuminating the subject with light from the light source such that the contrast agent in vivo may interact with and modify the illuminating light;
• (e) detecting modified light with the light detector after passage of source light through an opaque region of the body and possible interaction and modification of the source light by the contrast agent;
• (f) determining a positional estimate of one or more metastatic cancers types and sites based upon said modified, detected light;
• and,
• (g) generating an output image in response to said measurement;
• (h) treating tissue at said positional estimate of cancer;
• and,
• (i) repeating steps (d) through (h) until a diagnostic or therapeutic endpoint is reached.